Product information

From Health Canada

New search

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Marketed

Current status date:

2006-09-19

Original market date: See footnote 1

2006-09-19

Product name:

MENOPUR

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section .

DIN:

02283093

Product Monograph/Veterinary Labelling:

Date: 2008-01-11 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company: 

FERRING INC
500  200 Yorkland Blvd
Toronto
Ontario
Canada  M2J 5C1

Class: 

Human

Dosage form(s):

Powder For Solution

Route(s) of administration:

Subcutaneous

Number of active ingredient(s):

1

Schedule(s):

Schedule D,  Prescription  

Biosimilar Biologic Drug:

No

American Hospital Formulary Service (AHFS): See footnote 3

68:18.00   GONADOTROPINS AND ANTIGONADOTROPINS

Anatomical Therapeutic Chemical (ATC): See footnote 4

G03GA02  HUMAN MENOPAUSAL GONADOTROPHIN

Active ingredient group (AIG) number:See footnote 5

0149345001

List of active ingredient(s)
Active ingredient(s) Strength
MENOTROPINS 75 UNIT / VIAL

Application information

Related information

Contact us

Version 3.8.0
Date modified: